Pro-Dex (Pro-Dex) Risk Assessment

View and export this data going back to 1986. Start your Free Trial

What is Pro-Dex Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Pro-Dex is: Low Risk: Strong fundamentals, worth long-term holding.

Competitive Comparison of Pro-Dex's Risk Assessment

For the Medical Instruments & Supplies subindustry, Pro-Dex's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pro-Dex's Risk Assessment Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Pro-Dex's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Pro-Dex's Risk Assessment falls into.

Pro-Dex (NAS:PDEX) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Pro-Dex Risk Assessment Related Terms

Thank you for viewing the detailed overview of Pro-Dex's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Pro-Dex (Pro-Dex) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pro-Dex Inc (NAS:PDEX) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

PDXN:Germany

Address

2361 McGaw Avenue, Irvine, CA, USA, 92614

Website

https://www.pro-dex.com

Pro-Dex Inc is engaged in designing, developing, and manufacturing powered rotary drive surgical and dental instruments used primarily in the orthopedic, spine, maxocranial facial and dental markets. The company also designs and manufactures multi-axis motion control systems used in factory automation and scientific research markets. In addition, the company provides engineering consulting and placement services, as well as quality and regulatory consulting services. Most of the company's revenue is derived from designing, developing, and manufacturing surgical devices for the medical device and dental industries.

Executives

Angelita Rebamontan Domingo	director	1431 MADISON ST., TUSTIN CA 92782
Van Kirk Richard Lee Jr	director, officer: Chief Executive Officer	34 DEER CREEK, IRVINE CA 92604
Philp Katrina Marie Kramer	director	5501 NANTUCKET PL, MINNETONKA MN 55345
Farrell William James Iii	director	20200 COTTAGEWOOD RD, DEEPHAVEN MN 55331
Peter O. Haeg	10 percent owner	12701 WHITEWATER DR, SUITE 190, MINNETONKA MN 55343
Alisha Charlton	officer: Chief Financial Officer	25541 COMMERCENTRE DRIVE, LAKE FOREST CA 92630
Nicholas John Swenson	10 percent owner	5000 WEST 36TH STREET, SUITE 130, MINNEAPOLIS MN 55416
Raymond E Cabillot	director	3033 EXCELSIOR BLVD., STE 560, MINNEAPOLIS MN 55416
David Hovda	director
Farnam Street Partners Lp /mn	10 percent owner	3033 EXCELSIOR BOULEVARD, MINNEAPOLIS, MINNEAPOLIS MN 55416
Ao Partners I, Lp	10 percent owner	5000 WEST 36TH STREET, SUITE 130, MINNEAPOLIS MN 55416
David Holder	director	1052 CHARWOOD LANE, SANTA ANA CA 92705
William L Healey	director	101 BULLITT LANE, STE 450, LOUISVILLE KY 40222
Michael J Berthelot	director	P O BOX 7277, RANCHO SANTA FE CA 92067
George J Isaac	director	36 WHISPER DRIVE, WORCESTER MA 01609